FDA approval Glyburide – Micronase clinical trails
Home       Treatment        Side Effects       Glyburide       FDA Aproval

 

FDA approval for Glyburide – Micronase Diabeta

The approval of Diabeta pills by the FDA were not on mere notices. This approval was based on a review of clinical trails and studies by double-blind, placebo controlled department, which was the data from six US departments. These included around 4500-5000 patients who suffered from diabetes of type2. This product is saled under the name Micronase, the manufacturer is Dr Reddy. The data transmitted by FDA had some positive approach towards Glyburide.

According to these reports Glyburide have the additional blood glucose lowering advantages that is offered by none other medicines or drugs. This help to reduce the sugar or the glucose levels in the body, where only dietary changes have less effect to control the diabetes of type2.Thus the treatment with Diabeta in the near future can be considered as the best. FDA required the drug to include a warning in their label that use Micronase is restricted only for diabetes patients. In July 2003 American Association noticed Glyburide drug was given even to patients suffering from heart problems

Thus in July 2004 the Food and Drug Association of America (US) included some warning sections with the Micronase. FDA has approved Glyburide to be produced by Dr.Reddy as the manufacturer under Micronase in US. Micronase is usually provided with doses of 1.25mg, 2.5mg and 5mg. Generic Glyburide or the Micronase do not serve as a good treatment for type1 diabetes. The treatment of the drug is very simple which is also prescribed by the FDA.
 

Home       Treatment        Side Effects       Glyburide       FDA Aproval